Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Analyst Ratings
Downgrades
News
Maxim Group Downgrades Synaptogenix to Hold
Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:SNPX) from Buy to Hold.
by
Benzinga Newsdesk
December 19, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:
SNPX
) from Buy to Hold.
Total
0
Shares
Share
0
Tweet
0
Share
0
Share
0
Share
0
Share
0